Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
China flag China · Delayed Price · Currency is CNY
39.07
-0.22 (-0.56%)
Apr 29, 2026, 3:00 PM CST

SHA:603392 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
2,4352,3883,8195,1931,416
Upgrade
Short-Term Investments
1,168480--200
Upgrade
Trading Asset Securities
1,4472,5102,0552,00940.39
Upgrade
Cash & Short-Term Investments
5,0505,3785,8747,2011,656
Upgrade
Cash Growth
-6.10%-8.44%-18.43%334.83%103.56%
Upgrade
Accounts Receivable
1,6382,0642,9993,9602,277
Upgrade
Other Receivables
97.6435.9648.715.1512.45
Upgrade
Receivables
1,7382,1043,0533,9702,292
Upgrade
Inventory
702.08863.19905.48869.14593.17
Upgrade
Other Current Assets
36.5729.44469.42139.4105.2
Upgrade
Total Current Assets
7,5268,37510,30212,1804,647
Upgrade
Property, Plant & Equipment
3,5183,5382,6412,2351,703
Upgrade
Long-Term Investments
1,2921,36212.01911.361.3
Upgrade
Other Intangible Assets
797.38512.46508.28292.5289.92
Upgrade
Long-Term Deferred Tax Assets
338.18243.33157.9566.0168.97
Upgrade
Long-Term Deferred Charges
292.39363.85214.29172.3727.18
Upgrade
Other Long-Term Assets
280.67294.671,879372.3249.09
Upgrade
Total Assets
14,04414,68915,71516,2307,046
Upgrade
Accounts Payable
143.61137.94234.28275.47154.08
Upgrade
Accrued Expenses
641.71915.891,6532,5721,541
Upgrade
Short-Term Debt
133.66103.6281.14140.14235.64
Upgrade
Current Portion of Long-Term Debt
56.8565.6887.193.07-
Upgrade
Current Portion of Leases
19.5238.4313.313.7313.93
Upgrade
Current Income Taxes Payable
0.438.597.4999.02146.55
Upgrade
Current Unearned Revenue
41.0548.1570.3882.2870.3
Upgrade
Other Current Liabilities
765.4693.76523.42299.34204.64
Upgrade
Total Current Liabilities
1,8022,0122,6703,4852,366
Upgrade
Long-Term Debt
98.7994.19115.36102.494.9
Upgrade
Long-Term Leases
45.5780.9712.3618.4332.59
Upgrade
Long-Term Unearned Revenue
64.3954.233.6541.3776.44
Upgrade
Long-Term Deferred Tax Liabilities
---17.15-
Upgrade
Other Long-Term Liabilities
----3.8
Upgrade
Total Liabilities
2,0112,2412,8313,6652,483
Upgrade
Common Stock
1,2641,2651,268906.07607.04
Upgrade
Additional Paid-In Capital
3,0483,1393,3123,729445.83
Upgrade
Retained Earnings
7,5527,9508,2507,9063,413
Upgrade
Treasury Stock
--92.17-129.42-200.17-
Upgrade
Total Common Equity
11,86512,26312,70112,3414,466
Upgrade
Minority Interest
168.46185.16183.06223.6396.2
Upgrade
Shareholders' Equity
12,03312,44812,88412,5654,562
Upgrade
Total Liabilities & Equity
14,04414,68915,71516,2307,046
Upgrade
Total Debt
354.39382.91309.35277.86287.06
Upgrade
Net Cash (Debt)
4,6954,9955,5656,9231,369
Upgrade
Net Cash Growth
-6.00%-10.23%-19.63%405.71%86.03%
Upgrade
Net Cash Per Share
3.653.764.425.541.11
Upgrade
Filing Date Shares Outstanding
1,2641,2651,2681,2681,232
Upgrade
Total Common Shares Outstanding
1,2641,2651,2681,2681,232
Upgrade
Working Capital
5,7246,3637,6328,6952,281
Upgrade
Book Value Per Share
9.389.6910.019.733.62
Upgrade
Tangible Book Value
11,06711,75012,19212,0494,176
Upgrade
Tangible Book Value Per Share
8.759.299.619.503.39
Upgrade
Buildings
1,557779.65724.87628.89392.67
Upgrade
Machinery
2,1271,7641,5101,185666.87
Upgrade
Construction In Progress
571.791,469814.56720.51924.38
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.